M Mîrşeanu, S Dumitru, C Sîntimbreanu, V Rădoi, G Orăşeanu, M Stănescu, E Jianu, L Burtică, C Pîrvu, A Petrescu
{"title":"[The efficacy of Macronil in treating acute respiratory infections in children 0 to 5 years old].","authors":"M Mîrşeanu, S Dumitru, C Sîntimbreanu, V Rădoi, G Orăşeanu, M Stănescu, E Jianu, L Burtică, C Pîrvu, A Petrescu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The authors followed the efficiency of product Macronil in association with the usual (antibiotic and symptomatic) treatments in acute, viral respiratory infections in 62 children, 0-5 years old, admitted into hospital. Besides the usual treatment (25 cases--control group) Macronil was administered in 37 cases (experimental group). A significant improvement was found in clinical evolution (duration of disease evolution, improvement of general state, good appetite, fever duration, increase in weight) of the experimental group versus the control group. An important reduction (twice) of the pharyngeal viral population appeared in the experimental group treated with Macronil. In the control group, the viral flora, remained, practically, the same after treatment.</p>","PeriodicalId":76449,"journal":{"name":"Revista de pediatrie, obstetrica si ginecologie. Pediatria","volume":"38 4","pages":"375-82"},"PeriodicalIF":0.0000,"publicationDate":"1989-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de pediatrie, obstetrica si ginecologie. Pediatria","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The authors followed the efficiency of product Macronil in association with the usual (antibiotic and symptomatic) treatments in acute, viral respiratory infections in 62 children, 0-5 years old, admitted into hospital. Besides the usual treatment (25 cases--control group) Macronil was administered in 37 cases (experimental group). A significant improvement was found in clinical evolution (duration of disease evolution, improvement of general state, good appetite, fever duration, increase in weight) of the experimental group versus the control group. An important reduction (twice) of the pharyngeal viral population appeared in the experimental group treated with Macronil. In the control group, the viral flora, remained, practically, the same after treatment.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
